Good morning, and welcome to the Nurix Therapeutics Conference Call. I'm Arthur Sands, President and CEO. And I'm joined today on this call by Gwenn Hansen, our Chief Scientific Officer; Paula ...

Good evening, everyone. My name is Arthur Sands. I'm President and CEO of Nurix Therapeutics. And I'd like to welcome you to our 2025 Investor and Analyst event broadcasting here from Orlando, Florida ...

The awareness of women in terms of health is gaining significance in contemporary medical care, particularly in matters of blood cancers such as Chronic Lymphocytic Leukemia. This disorder impacts ...